BeiGene, Ltd.
Utility Patents

Last updated:

List of all BeiGene, Ltd. patents 18 in total

Status Patent
Grant
Utility: Interoperable platform for reducing redundancy in medical database management External link
Filling date: 26 Sep 2025 Issue date: 19 Jul 2022
Grant
Utility: BTK inhibitors with improved dual selectivity External link
Filling date: 26 Sep 2025 Issue date: 5 Jul 2022
Grant
Utility: Imidazo[1,5-a]pyrazine derivatives as PI3Kdelta inhibitors External link
Filling date: 26 Sep 2025 Issue date: 11 Jan 2022
Grant
Utility: Anti-TIGIT antibodies and their use as therapeutics and diagnostics External link
Filling date: 26 Sep 2025 Issue date: 4 Jan 2022
Grant
Utility: Treatment cancers using a combination comprising PARP inhibitors External link
Filling date: 26 Sep 2025 Issue date: 21 Dec 2021
Grant
Utility: Anti-Tim-3 antibodies and use thereof External link
Filling date: 26 Sep 2025 Issue date: 21 Dec 2021
Grant
Utility: Imidazo[1,5-a]pyrazine derivatives as PI3K .delta. inhibitors External link
Filling date: 26 Sep 2025 Issue date: 5 Oct 2021
Grant
Utility: Crystalline forms of salts of fused penta-cyclic dihydrodiazepinocarbazolones, and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 26 Jan 2021
Grant
Utility: 5 or 8-substituted imidazo [1,5-a] pyridines as selective inhibitors of indoleamine and/or tryptophane 2,3-dioxygenases External link
Filling date: 26 Sep 2025 Issue date: 5 Jan 2021
Grant
Utility: Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer External link
Filling date: 26 Sep 2025 Issue date: 15 Dec 2020
Grant
Utility: 5 or 8-substituted imidazo[1,5-a]pyridines as indoleamine and/or tryptophane 2,3-dioxygenases External link
Filling date: 26 Sep 2025 Issue date: 12 May 2020
Grant
Utility: Fused tricyclic compounds as Raf kinase inhibitors External link
Filling date: 26 Sep 2025 Issue date: 3 Mar 2020
Grant
Utility: Substituted pyrazolo[1,5-a]pyrimidines as Bruton's tyrosine kinase modulators External link
Filling date: 26 Sep 2025 Issue date: 25 Feb 2020
Grant
Utility: Fused tricyclic urea compounds as Raf kinase and/or Raf kinase dimer inhibitors External link
Filling date: 26 Sep 2025 Issue date: 18 Feb 2020
Grant
Utility: Anti-PD-L1 antibodies and their use as therapeutics and diagnostics External link
Filling date: 26 Sep 2025 Issue date: 28 Jan 2020
Grant
Utility: Anti-PD1 antibodies and their use as therapeutics and diagnostics External link
Filling date: 26 Sep 2025 Issue date: 31 Dec 2019
Grant
Utility: Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors External link
Filling date: 26 Sep 2025 Issue date: 10 Dec 2019
Grant
Utility: Process for preparing a PARP inhibitor, crystalline forms, and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 29 Oct 2019

Showing 1 to 18 of 18 patents.